No Association Found Between Opioid Use, Breast Cancer Recurrence
the Cancer Therapy Advisor take:
No clinical evidence was found to support a relationship between opioid prescriptions used to manage pain and risk of breast cancer recurrence, according to an article published online in the journal Cancer.
A total of 34,188 patients with incident, early stage breast cancer diagnosed between 1996 and 2008 in Denmark were identified from the Danish Breast Cancer Cooperative Group Registry. Data regarding opioid prescriptions were gathered from the Danish National Prescription Registry.
Results showed no correlation between ever-use of opioids (regardless of opioid type, strength, chronicity of use, or cumulative dose) and breast cancer recurrence (crude hazard ratio [HR], 0.98; 95% CI: 0.90, 1.1; adjusted HR, 1.0; 95% CI: 0.92, 1.1).
Furthermore, breast cancer recurrence rates were reduced among patients who used strongly (but not weakly) immunosuppressive opioids. The authors noted this could have possibly been due to channeling bias among those with a high competing risk.
The study argued the findings were important for patients with cancer given that opioids are commonly used to manage pain related to comorbid conditions.
No clinical evidence found to support a relationship between opioid prescriptions used to manage pain and risk of breast cancer recurrence.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Massage and Cancer
- Pembrolizumab May Lead to Favorable Long-Term Outcomes in Head and Neck Cancer
- Biomarker-Based Blood Test May Extend Reach of CT Screening for Certain Lung Cancers
- Next-Generation Sequencing Adds Value by Detecting More Mutations Than Polymerase Chain Reaction in Melanoma
- Tucatinib May Be A Safe, Novel Treatment for ERBB2/HER2-Positive Breast Cancer